ENSC
ENSC
NASDAQ · Biotechnology

Ensysce Biosciences Inc

$0.46
+0.00 (+0.52%)
As of Feb 8, 2:35 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +8,133.6% upside
Low Target $25.94
Average Target $37.99
High Target $62.46
Current Price $0.46
Current
$0.46
Target
$37.99
$25.94 $37.99 avg $62.46
Scenario Analysis
Bear Case
$25.94
5,522.0%
Low target
Base Case
$37.99
+8,133.6%
Avg target
Bull Case
$62.46
+13,437.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$40.39
-98.9% from high
52-Week Low
$31.92
+-98.6% from low
Target vs 52W High
$37.99
-5.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%